Mass spectrometry-based analysis of glycoproteins and its clinical applications in cancer biomarker discovery

被引：33
|
作者：
Liu, Huan [1 ,2 ]
Zhang, Ningbo [1 ,2 ]
Wan, Debin [1 ,2 ]
Cui, Meng [1 ]
Liu, Zhiqiang [1 ]
Liu, Shuying [1 ]
机构：
[1] Chinese Acad Sci, Changchun Inst Appl Chem, Changchun Ctr Mass Spectrometry, 5625 Renmin St, Changchun 130022, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100039, Peoples R China
来源：
CLINICAL PROTEOMICS | 2014年 / 11卷
基金：
中国国家自然科学基金;
关键词：
Mass spectrometry; Glycoproteins; Cancer biomarker; ELECTRON DETACHMENT DISSOCIATION; N-LINKED GLYCOPROTEINS; NANO-LC-MS/MS; STRUCTURAL-CHARACTERIZATION; PROTEIN GLYCOSYLATION; QUANTITATIVE-ANALYSIS; LIVER-CANCER; IDENTIFICATION; SERUM; GLYCANS;
D O I：
10.1186/1559-0275-11-14
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Glycosylation is one of the most important posttranslational modifications of proteins and plays essential roles in various biological processes. Aberration in the glycan moieties of glycoproteins is associated with many diseases. It is especially critical to develop the rapid and sensitive methods for analysis of aberrant glycoproteins associated with diseases. Mass spectrometry (MS) has become a powerful tool for glycoprotein analysis. Especially, tandem mass spectrometry can provide highly informative fragments for structural identification of glycoproteins. This review provides an overview of the development of MS technologies and their applications in identification of abnormal glycoproteins and glycans in human serum to screen cancer biomarkers in recent years.
引用
收藏
页数：9
相关论文
共 50 条
  • [21] Mass spectrometry-based protein biomarker discovery in neurodevelopmental disorders
    Wormwood, Kelly
    Wetie, Armand Ngounou
    Charette, Laci
    Ryan, Jeanne
    Dupree, Emmalyn
    Woods, Alisa
    Darie, Costel
    PROTEIN SCIENCE, 2015, 24 : 244 - 245
  • [22] Mass spectrometry-based tear proteomics for noninvasive biomarker discovery
    Ponzini, Erika
    Santambrogio, Carlo
    De Palma, Antonella
    Mauri, Pierluigi
    Tavazzi, Silvia
    Grandori, Rita
    MASS SPECTROMETRY REVIEWS, 2022, 41 (05) : 842 - 860
  • [23] Variant biomarker discovery using mass spectrometry-based proteogenomics
    Reilly, Luke
    Seddighi, Sahba
    Singleton, Andrew B.
    Cookson, Mark R.
    Ward, Michael E.
    Qi, Yue A.
    FRONTIERS IN AGING, 2023, 4
  • [24] Plasma Mass Spectrometry-Based Proteomic Biomarker Discovery for Endometriosis
    Rogers, Peter A. W.
    Rao, Sushma R.
    Boughton, Berin
    Snel, Marten
    Griffiths, Meaghan
    Girling, Jane
    Holdsworth-Carson, Sarah
    REPRODUCTIVE SCIENCES, 2023, 30 : 200A - 200A
  • [25] Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma
    Fujii, Kiyonaga
    Nakamura, Haruhiko
    Nishimura, Toshihide
    EXPERT REVIEW OF PROTEOMICS, 2017, 14 (04) : 373 - 386
  • [26] Mass spectrometry-based analysis of IgG glycosylation and its applications
    Liu, Xuejiao
    Sun, Zhenyu
    Li, Zhonghua
    Zhang, Ying
    Lu, Haojie
    INTERNATIONAL JOURNAL OF MASS SPECTROMETRY, 2022, 474
  • [27] Mass spectrometry-based phosphoproteomics in clinical applications
    Wu, Xiaofeng
    Liu, Yi-Kai
    Iliuk, Anton B.
    Tao, W. Andy
    TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2023, 163
  • [28] Clinical applications of mass spectrometry-based proteomics in cancer: Where are we?
    Boys, Emma L.
    Liu, Jia
    Robinson, Phillip J.
    Reddel, Roger R.
    PROTEOMICS, 2023, 23 (7-8)
  • [29] Mass spectrometry-based antigen discovery for cancer immunotherapy
    Bassani-Sternberg, Michal
    Coukos, George
    CURRENT OPINION IN IMMUNOLOGY, 2016, 41 : 9 - 17
  • [30] NOVEL MASS SPECTROMETRY-BASED STRATEGIES APPLIED TO BIOMARKER DISCOVERY AND EVALUATION
    Domon, Bruno
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S85 - S85
12345